We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AtheroGenics Drops Highest Dose in Diabetes Drug Trial
AtheroGenics Drops Highest Dose in Diabetes Drug Trial
December 12, 2007
The highest dose arm in a clinical trial of the investigational diabetes drug AGI-1067 has been halted due to liver toxicity.